ArticleJournal of atherosclerosis and thrombosis2023

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker.

Michio ShimabukuroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.